DBV Technologies (DBVT) Change in Cash (2020 - 2026)
DBV Technologies (DBVT) posted Change in Cash of -$54.2 million for Q2 2026, down 254.86% sequentially from $35.0 million in Q1 2026, and down 160.02% YoY from $90.3 million in Q2 2025.
DBV Technologies (DBVT) Change in Cash (2020 - 2026) Analysis & Trends
DBV Technologies has reported Change in Cash for 7 years, with the latest figure at -$54.2 million in Q2 2026.
- Quarterly Change in Cash fell 160.02% year-over-year to -$54.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $71.7 million (up 93.6% YoY) and the FY2025 annual result came in at $161.7 million, up 248.48% from the prior year.
- Change in Cash eased to -$54.2 million in Q2 2026 per DBVT's latest filing, from $35.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $173.9 million in Q2 2022 and troughed at -$54.2 million in Q2 2026.
- A 5-year average of $5.4 million and a median of -$17.6 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 429.27% in 2023, then jumped 988.83% in 2025.
- Over 5 years, Change in Cash stood at -$3.5 million in 2022, then plunged by 123.48% to -$7.8 million in 2023, then slumped by 80.07% to -$14.0 million in 2024, then surged by 988.83% to $124.3 million in 2025, then plunged by 143.59% to -$54.2 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$54.2 million, $35.0 million, and $124.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | -54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.20 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 124.33 Mn |
| Sep 30, 2025 | -33.42 Mn |
| Jun 30, 2025 | 90.30 Mn |
| Mar 31, 2025 | -19.50 Mn |
| Dec 31, 2024 | -13.99 Mn |
| Sep 30, 2024 | -19.77 Mn |
| Jun 30, 2024 | -35.31 Mn |
| Mar 31, 2024 | -39.84 Mn |
| Dec 31, 2023 | -7.77 Mn |
| Sep 30, 2023 | -24.83 Mn |
| Jun 30, 2023 | -18.33 Mn |
| Mar 31, 2023 | -16.91 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Sep 30, 2022 | -35.30 Mn |
| Jun 30, 2022 | 173.86 Mn |
| Mar 31, 2022 | -3.19 Mn |
| Dec 31, 2021 | -20.89 Mn |
| Sep 30, 2021 | -27.29 Mn |